title: The role of dynamic renal scintigraphy on clinical decision making in hydronephrotic children.
abstract: Hydronephrosis may be related to an obstructive cause, ureteropelvic/uretero-vesical junction obstruction or nonobstructive [vesicoureteral reflux (VUR)]. When an obstructive pathology is considered, dynamic renal scintigraphy may help to predict whether it is a true obstruction or not. In this study, we aimed to determine the contribution of dynamic renal scintigraphy with [99] mTc-MAG-3 to the clinical decision-making for surgery in hydronephrotic children. Files of the patients evaluated by MAG-3 scintigraphy for antenatal (AH)/postnatal (PH) hydronephrosis between 1992 and 2014 were reviewed. Gender, age, hydronephrosis (HN) grade by ultrasound (US), presence of VUR, MAG-3 result (obstructive vs. nonobstructive), ultimate diagnosis, and need for surgery were assessed. Cases with double collecting system and neurogenic bladder were excluded from the study. All of the patients had normal serum creatinine and eGFR. There were a total of 178 patients with 218 hydronephrotic renal units (mean age 34.7 ± 52.7 months; male/ female = 121/57, AH of 62%). MAG-3 was nonobstructive in 134 and obstructive in 84 hydronephrotic renal units. MAG-3 was obstructive in 47 of 121 (39%) males and 30 of 57 (53%) females (P = 0.058, odds ratio (OR) for obstruction was 1.9 for girls). MAG-3 was obstructive in 47 of 135 (35%) units with AH and 37 of 83 (45%) units with PH (P = 0.137). In 81 units with the society of fetal urology-4 HN by US, MAG-3 was obstructive in 55 (68%), and surgery was required in 52 of 55 (95%). Surgery was required for only two (7%) of the remaining 26 units with nonobstructive dilatation (P <0.001, sensitivity 96%, specificity 89%, OR 208). Antero-posterior diameter >16.5 mm was the best cutoff level for predicting obstruction by MAG-3 (sensitivity 75.2%; specificity 71%; OR 3.8). MAG-3 significantly affects clinical decision for surgery in HN. Hydronephrotic girls have more risk in terms of true obstruction. Combining MAG-3 with US improves the discrimination of true obstruction during follow-up.
authors.affiliation: Department of Pediatrics, Division of Nephrology, Medical Faculty, Dokuz Eylul University, Izmir, Turkey.
authors.forename: Seçil Arslansoyu
authors.initials: SA
authors.lastname: Çamlar
authors.affiliation: Department of Pediatrics, Division of Nephrology, Medical Faculty, Dokuz Eylul University, Izmir, Turkey.
authors.forename: Nazlı
authors.initials: N
authors.lastname: Deveci
authors.affiliation: Department of Pediatrics, Division of Nephrology, Medical Faculty, Dokuz Eylul University, Izmir, Turkey.
authors.forename: Alper
authors.initials: A
authors.lastname: Soylu
authors.affiliation: Department of Pediatrics, Division of Nephrology, Medical Faculty, Dokuz Eylul University, Izmir, Turkey.
authors.forename: Mehmet Atilla
authors.initials: MA
authors.lastname: Türkmen
authors.affiliation: Department of Pediatrics, Division of Nephrology, Medical Faculty, Dokuz Eylul University, Izmir, Turkey.
authors.forename: Derya
authors.initials: D
authors.lastname: Özmen
authors.affiliation: Department of Nuclear Medicine, Medical Faculty, Dokuz Eylul University, Izmir, Turkey.
authors.forename: Gamze
authors.initials: G
authors.lastname: Çapakaya
authors.affiliation: Department of Pediatrics, Division of Nephrology, Medical Faculty, Dokuz Eylul University, Izmir, Turkey.
authors.forename: Salih
authors.initials: S
authors.lastname: Kavukçu
mesh_terms: D015415:Biomarkers / Q000097:blood; D002648:Child; D002675:Child, Preschool; D000066491:Clinical Decision-Making; D003404:Creatinine / Q000097:blood; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D006869:Hydronephrosis / Q000000981:diagnostic imaging* / Q000209:etiology / Q000503:physiopathology / Q000601:surgery; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011237:Predictive Value of Tests; D011379:Prognosis; D011877:Radionuclide Imaging / Q000379:methods*; D019275:Radiopharmaceuticals / Q000008:administration & dosage*; D018570:Risk Assessment; D012307:Risk Factors; D012737:Sex Factors; D017263:Technetium Tc 99m Mertiatide / Q000008:administration & dosage*; D014463:Ultrasonography
chemical_list: D015415:Biomarkers; D019275:Radiopharmaceuticals; D017263:Technetium Tc 99m Mertiatide; D003404:Creatinine